| Tag | Content |
|---|
EnhancerAtlas ID | HS012-17770 |
Organism | Homo sapiens |
Tissue/cell | Caco-2 |
Coordinate | chr22:32072510-32073330 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF5 | MA0599.1 | chr22:32072862-32072872 | GCCCCGCCCC | + | 6.02 | | NFYA | MA0060.3 | chr22:32072885-32072896 | AGCCAATCAGA | + | 6.32 | | USF1 | MA0093.2 | chr22:32072777-32072788 | ACCACGTGACC | + | 6.32 | | USF2 | MA0526.2 | chr22:32072775-32072791 | TAACCACGTGACCCTC | - | 6.33 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_10007 | chr22:32072142-32073464 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH22I031676 | chr22 | 32072188 | 32073393 |
|
Enhancer Sequence | GCGAGTCTTT CTCCCAGGCT GGAGTGCAGT GGCGCGACCT CGGCTCACGG CACCTACAGT 60
CTCCCGAGTT CAAGCGATTC TTCTGCCTCA GCTTCCCGAG TAGCTGGGAT TACAGGCGCG 120
CGCCACCACT CCCGGCTAAT TTTTTGTATT TTTAGTAGAG TCACCAGGTT GGCCAGGCCT 180
GTCTCAAGTG ATCCGCCCGC CTCTGCCTCC CAAAGTGCTG GGATTACAGG CTTGAGTCAC 240
CGCGCCCGGC CCACGTGGCG AGTCTTAACC ACGTGACCCT CCCCGCTCTC CAGCCCGGCA 300
GGTACCAGCA AAGGACTAGC AGCCTCCTCC AATATGGATA GCTTCTCGGA TGGCCCCGCC 360
CCTCCGGAGA GCTGCAGCCA ATCAGACGGC GTGAGGCCAG CAGTGGGTGC GGCTGCGCTT 420
GGCGCTGCGC ATATCCGAAT ACCAGGAAGT GCCCGGTTTC GCTGTCAGTG CTCGGGCAGC 480
TAGAATCCAG GTCCCTTGAG GAATAATTTA AGAAGGGGTG GAGAAAAATT AGGGGGCGTC 540
TTCAAATATT CAGAGAGTCA GCGAGGTAAA GAGGACTTGG GCAGGTCTGT GTAGCAACGG 600
GGGCGGGAAT CATTCATTGA CGCATGAAGT ATTTCCTGAG CTCCCACCAC GTAAGACCAA 660
GTTTTGTTCT AGATGTCCGA GGGGCCAGAG TGAATATAGC AAAGTCTTTG ACCTCAAGGA 720
GCTTAACGTG AATAATATGG GGACGTGGTG GTGTTAAAAA ATATATAAAA CAGGCCGGGT 780
GCCGTGGCTC ACGCCTGTAA TCCCAGCTCT TTGGGAGGCC 820
|
